ClinicalTrials.Veeva

Menu

Predictive Value of Mid-luteal Serum Progesterone Levels in Egg Donation Cycles

I

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status

Completed

Conditions

Pregnancy

Treatments

Other: Progesterone 25-75
Other: Progesterone <25, >75

Study type

Observational

Funder types

Other

Identifiers

NCT02696694
1511-VLC-061-EL
IVI-EST-2015-01 (Other Identifier)

Details and patient eligibility

About

This study aims to investigate the impact of serum progesterone concentrations on the day of embryo transfer in egg donation cycles under hormonal replacement therapy. As secondary outcomes, the investigators will investigate if endometrial volume measured by three-dimensional (3D) ultrasound on the day of embryo transfer is related with progesterone levels and with chances of pregnancy.

Enrollment

242 patients

Sex

Female

Ages

25 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age<50 yo
  • BMI < 30Kg/m2
  • Hormonal replacement cycle
  • Endometrial thickness >6.5 mm during proliferative phase
  • Transfer of one or two blastocyst grade A-B according to ASEBIR

Exclusion criteria

  • Uterine pathology
  • Cryptozoospermia
  • Severe implantation failure (>6 GQ embryos transferred without success)

Trial design

242 participants in 2 patient groups

P25-P75
Description:
serum progesterone between 25 and 75 percentile
Treatment:
Other: Progesterone 25-75
<P25 ó >P75
Description:
serum progesterone \<25 or \>75 percentile
Treatment:
Other: Progesterone <25, >75

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems